Latest filing published 27 May 2020 for Windtree Therapeutics INC, €7,301.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mary B. Templeton Esq.: trading record in brief
Mary B. Templeton Esq. appears in our data through filings on Windtree Therapeutics Inc shares, published by SEC (Form 4). We count 10 filings; the first trade dates from 30 September 2011 and the latest from 22 May 2020.
Purchases make up the whole of the open-market record (2 purchases, €7,301). The amount is not disclosed for 1 filing. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 8 share grants. Since January 2020: 1 purchase and no sales on the market.
The record was last updated on 27 May 2020 with an open-market purchase (€7,301) in Windtree Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 33 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Mary B. Templeton Esq.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,103 shares@ US$7.25Common StockSEC:0001437749-20-011879:0Canonical exit: 20 Aug 2020 (T+90)
- 1,347 shares@ US$1.6745.8% of flowCommon StockSEC:0001437749-16-036123:0
- 1,166 shares@ US$1.9354.2% of flowCommon StockSEC:0001437749-16-036123:1
- 804 sharesCommon StockSEC:0001140361-16-050177:0
- 2,630 sharesCommon StockSEC:0001140361-16-050177:1
- 16,667 sharesCommon StockSEC:0001140361-15-028593:0Canonical exit: 20 Oct 2015 (T+90)
- 1,539 shares@ US$2.68Common StockSEC:0001140361-12-023607:0
7 of 7 declarations